Globela Pharma Pvt Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Globela Pharma Pvt Ltd. - overview
Established
2006
Location
Surat, Gujarat, India
Primary Industry
Pharmaceuticals
About
Founded in 2006 and based in Surat, India, Globela Pharma Pvt Ltd. is a pharmaceutical company focused on developing and manufacturing high-quality products across various therapeutic areas. Globela Pharma Pvt Ltd. specializes in the development and manufacturing of pharmaceutical products.
The company was founded by Priyank Vaghashia and is headquartered in Surat, India. In October 2021, Somerset Indus Capital Partners acquired a minority stake in Globela Pharma Pvt Ltd for over INR 74. 4 crore, totaling the amount raised to INR 744. 00 mn.
The company has engaged in one deal to date, with its latest funding round being a GROWTH round. Globela Pharma Pvt Ltd. specializes in the development and manufacturing of high-quality pharmaceutical products across a wide range of therapeutic areas, including Gastroenterology, Cardiovascular health, Diabetology, Oncology, Pain management, and Nephrology. The company’s core offerings encompass Finished Dosage Formulations, DC Granules, Pellets (semi-finished products), Active Pharmaceutical Ingredients (APIs), and Intermediates, aiming to improve patient outcomes and provide effective treatment options.
In the most recent financial year, 2020, Globela Pharma reported a revenue of INR 12,334,226. 10 and an EBITDA of INR 2,015,493. 60. Globela Pharma intends to accelerate growth following its most recent deal in October 2021.
The company plans to expand its product lineup and enter new markets, although specific details regarding new products or geographic focus have not been disclosed. The recent funding will support the company's initiatives to enhance its market presence and product offerings.
Current Investors
Somerset Indus Capital Partners
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.globelapharma.com
Verticals
Manufacturing
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
Globela Pharma Pvt Ltd. - timeline of key events
Globela Pharma Pvt Ltd. - financials
| Fiscal Year Ended | Mar 31, 2012 | Mar 31, 2013 | Mar 31, 2014 | Mar 31, 2015 | Mar 31, 2016 | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | 215,741,426 | 279,637,237.5 | 406,859,256.4 | 587,198,729.7 | 761,765,916.5 | 874,237,733.7 | 1,431,998,058.3 | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | 29.6% | 45.5% | 44.3% | 29.7% | 14.8% | 63.8% | - | - | - |
| EBITDA (USD) | 6,554,964 | 7,110,234 | 9,385,123 | 11,373,824 | 18,754,965.7 | 45,009,003 | 60,639,617.2 | 95,775,601.6 | 142,856,193.4 | 264,593,856.6 | - | - | - |
| Operating Income (USD) | 2,735,160 | 2,967,598 | 5,334,384 | 4,845,921 | 13,054,986.7 | 38,246,064.2 | 50,656,092.8 | 85,028,541 | 117,415,692.9 | 205,823,606.2 | - | - | - |
| Operating Margin | - | - | - | 2.2% | 4.7% | 9.4% | 8.6% | 11.2% | 13.4% | 14.4% | - | - | - |
| % EBITDA Margin | - | - | - | 5.3% | 6.7% | 11.1% | 10.3% | 12.6% | 16.3% | 18.5% | - | - | - |
| NET Income (USD) | 299,553.8 | (895,654) | 1,346,482.2 | 756,501.1 | 6,058,102.3 | 23,541,574.7 | 41,298,906.5 | 58,824,151.9 | 74,957,304.6 | 145,076,174.6 | - | - | - |
| % Net Margin | - | - | - | 0.4% | 2.2% | 5.8% | 7.0% | 7.7% | 8.6% | 10.1% | - | - | - |
Globela Pharma Pvt Ltd. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | Completed | Globela Pharma Pvt Ltd. | - |
Displaying 1 - 1 of 1
Globela Pharma Pvt Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.